Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis

Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis

Pulmonary fibrosis (PF) is a serious and progressive fibrotic interstitial lung disease that is possibly life-threatening and that is characterized by fibroblast accumulation and collagen deposition. Nintedanib and pirfenidone are currently the only two FDA-approved oral medicines for PF. Some drugs...

Full description

Bibliographic Details
Main Authors: Yan Yu, Hongyao Liu, Liping Yuan, Meng Pan, Zhongwu Bei, Tinghong Ye, Zhiyong Qian
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Materials Today Bio
Subjects:
Pulmonary fibrosis
Ncl-Lips
Immune microenvironment
Reversal
EMT
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006424000395

Internet

http://www.sciencedirect.com/science/article/pii/S2590006424000395

Similar Items